Zobrazeno 1 - 5
of 5
pro vyhledávání: '"George, Schmieder"'
Autor:
Ulrike Blume-Peytavi, Walter Gubelin Harcha, Qinping Yang, George Schmieder, Maria Hordinsky, Giuseppe Micali, Manabu Ohyama, Liza Takiya, Fan Zhang, Gregor Schaefer, Robert Wolk, Urs Kerkmann
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 7:s187
Publikováno v:
Cutis. 109
Blisters and subsequent desquamation of the skin in the presence of acute edema is a well-known clinical phenomenon. In this case report, we describe a new variant that we have termed anasarca-induced desquamation in a 50-year-old man with molting of
Autor:
Christopher Sayed, Seth B Forman, Christos C. Zouboulis, Lucian Ionescu, Dominique Baeten, George Schmieder, Sophie Glatt, Seth D Seegobin, Jamie Weisman, Stevan Shaw, R. Rolleri, Gregor B.E. Jemec
Publikováno v:
JAMA dermatology, 157(11), 1279-1288. American Medical Association
JAMA Dermatol
JAMA Dermatol
Importance Hidradenitis suppurativa (HS) is a chronic inflammatory disease with a high burden for patients and limited existing therapeutic options. Objective To evaluate the efficacy and safety of bimekizumab, a monoclonal IgG1 antibody that selecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b4c1d0ed65479af00e672e072431b06
https://pure.amc.nl/en/publications/efficacy-and-safety-of-bimekizumab-in-moderate-to-severe-hidradenitis-suppurativa-a-phase-2-doubleblind-placebocontrolled-randomized-clinical-trial(3a0da2c2-2eb5-44a6-8d23-19510f4b019b).html
https://pure.amc.nl/en/publications/efficacy-and-safety-of-bimekizumab-in-moderate-to-severe-hidradenitis-suppurativa-a-phase-2-doubleblind-placebocontrolled-randomized-clinical-trial(3a0da2c2-2eb5-44a6-8d23-19510f4b019b).html
Autor:
Lawrence, Anderson, Michael, Jarratt, George, Schmieder, Stephen, Shumack, Janelle, Katsamas, Peter, Welburn
Publikováno v:
The Journal of clinical and aesthetic dermatology. 7(12)
Objective: To determine safety, tolerability, and systemic absorption of ingenol mebutate 0.05% gel applied for two consecutive days to treatment areas up to 100cm2 on the forearm(s) of patients with actinic keratosis. Design and setting: Two studies
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 1:s122
Not Available